Business Context and Reporting Period
Company: Evolv Technologies Holdings, Inc. (EVLV)
Filing Type: Form 8-K (Current Report)
Date of Report: October 24, 2024
Context: The Company is an emerging growth company incorporated in Delaware. This filing addresses a significant internal investigation into sales practices and the subsequent decision to withdraw reliance on previously issued financial statements.
Key Financial Metrics and Material Changes
Revenue Misstatement: An ad hoc committee of independent directors has preliminarily determined that revenue was prematurely or incorrectly recognized for periods between Q2 2022 and Q2 2024. The estimated net impact is approximately $4 million to $6 million through June 30, 2024. The vast majority of this amount is believed to be premature recognition rather than incorrect recognition.
Non-Reliance Periods: The Board has determined that investors should no longer rely on financial statements for:
- Fiscal years ended December 31, 2022 and 2023 (Form 10-K).
- Quarters and year-to-date periods ended June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023, September 30, 2023, March 31, 2024, and June 30, 2024 (Form 10-Q).
Cause of Misstatement: Certain sales, including those to a major channel partner, were subject to extra-contractual terms and conditions not shared with accounting personnel, the Audit Committee, or the independent auditor (PwC). Certain personnel engaged in misconduct regarding these transactions.
Other Metrics: The filing does not provide updated values for profit, cash flow, margins, debt, or liquidity. Previously reported metrics derived from revenue are considered misstated.
Guidance, Outlook, and Risks
Investigation Status: The internal investigation is ongoing. The Company is working to complete the investigation and prepare amendments to financial statements.
Regulatory Action: The Company has self-reported these issues to the SEC Division of Enforcement and is cooperating with an ongoing investigation.
Internal Controls: The Company expects to report one or more additional material weaknesses in internal control over financial reporting.
Filing Delays: The Company will delay the filing of its Form 10-Q for the period ended September 30, 2024, and will file a Form 12b-25 (Notification of Late Filing) to request additional time.
Forward-Looking Statements: The Company cautions that estimates regarding the investigation's outcome, duration, and financial impact are preliminary and subject to change.
Investor Verification Checklist
- Verify the final scope and dollar amount of the revenue restatement once the investigation concludes.
- Monitor the filing of amended Forms 10-K and 10-Q for the Non-Reliance Periods.
- Review the upcoming Form 12b-25 and the delayed Q3 2024 Form 10-Q for updated financial data.
- Assess the specific nature of the "extra-contractual terms" and the extent of personnel misconduct.
- Track the status of the SEC investigation and any potential enforcement actions.
- Confirm the identification and remediation of material weaknesses in internal controls.